On January 15, 2025, the Department of Health and Human Services (HHS) and Drug Enforcement Administration (DEA ... or dispensing controlled substances alongside new registration requirements.

Opens in a new tab or window Physicians would have to register with the Drug Enforcement Administration (DEA ... III-V controlled substances would need to apply for a special registration ...

The Drug Enforcement Administration released a notice of proposed rulemaking that would create a three-tiered special registration ... II-V controlled substances with the DEA.

Now, the DEA has released a potential ... to prescribe Schedule II to V controlled substances. Providers would also have to maintain a state telemedicine registration for each state they practice ...

For about half a decade now, Americans have had the ability to receive controlled substances via telehealth because requirements were relaxed during the Covid-19 pandemic. This has greatly ...

On Wednesday, the DEA released a proposed rule that would set up a special registration process for remote prescribing of Schedule II-V controlled substances such as Xanax, Vicodin and Adderall.

Healthcare providers will finally get a special registration to dispense controlled ... verification, electronic recordkeeping, and ongoing monitoring.” “We are pleased to see the DEA propose ...

“Upon careful review of the DEA’s draft Special Registration for remote prescribing of controlled substances, we have serious concerns about the feasibility of this proposal,” Kyle ...

Physicians would have to register with the Drug Enforcement Administration (DEA ... prescribe Schedule III-V controlled substances would need to apply for a special registration; substances ...